MTX-001 is an investigational biologic therapy being developed to address underlying biological deficiencies associated with impaired wound healing. The therapy is designed to deliver a concentrated ...

A phase 2 trial is investigating MTX-001, an injectable regenerative therapy, for patients with noninfected venous leg ulcers.

JERUSALEM, Feb 12 (Reuters) - MediWound (MDWD.O), opens new tab, an Israeli developer of products to treat burns and wounds using non-surgical tissue repair, said on Wednesday it was starting a Phase ...

A leg ulcer can be understood as a break in the skin, typically located on the feet or the lower part of the leg. Leg ulcers are generally diagnosed based on their appearance, though this can be ...

In normal conditions, contraction of lower extremity muscles and working intraluminal valves promote the forward flow of blood within veins. In venous insufficiency, reflux and/or obstruction in the ...

Please provide your email address to receive an email when new articles are posted on . Complete debridement was achieved by 63% of patients treated with EscharEx vs. 30.2% and 13.3% of comparison ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...